Status:
COMPLETED
An Initial Study of the Implementation of Digital Therapeutics for Substance Use Disorders in Primary Care
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Drug Use Disorders
Illicit Drug Use
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders in primary care. In this pilot study, the FDA-authorized reS...
Eligibility Criteria
Inclusion
- Had a primary care visit in a participating clinic during the pilot
- Screened positive for substance use
- Adult aged 18 years or older at time of visit
Exclusion
- None
Key Trial Info
Start Date :
May 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2023
Estimated Enrollment :
1552 Patients enrolled
Trial Details
Trial ID
NCT04907045
Start Date
May 6 2021
End Date
December 4 2023
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Washington
Seattle, Washington, United States, 98101